7 
implementation. For this purpose a review of authorities — the Public 
Health Service Act, the Occupational Safety and Health Act, the National 
Environmental Policy Act, and other relevant statutes — will be carried 
out. 
It should be noted that the National Science Board has adopted by 
resolution the NIH guidelines for all such research supported by the 
National Science Foundation. We anticipate similar letters of endorse- 
ment from all of the Federal agencies that are now conducting or supporting 
such research, or consider that they may do so in the near future. 
Since the NIH meeting with private industry in June and following 
publication of the NIH guidelines in the Federal Register , the Pharma- 
ceutical Manufacturers Association has been reviewing the applicability 
of the guidelines to industry research activities. The PMA has expressed 
general support for the guidelines with relatively minor revisions 
considered necessary to meet the needs of industry. 
In order to ensure that implementation of the guidelines within the 
NIH be achieved without delay, an NIH Office of Recombinant DNA Activi- 
ties was created in June to administer and coordinate activities. This 
office will serve as liaison to the institutional biohazard committees 
for administration of the guidelines. There will be special emphasis on 
activities pertaining to the operation and implementation of containment 
and safety practices and procedures. The NIH office will also closely 
monitor reports and information concerning accidents, containment, and 
safety research innovation. 
[ 819 ] 
